Compare Cytokinetics Inc (CYTK) vs PayPal Holdings, Inc. (PYPL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cytokinetics Inc vs PayPal Holdings, Inc. — how do they compare? Cytokinetics Inc trades at $76.67 (market cap $10.63B), while PayPal Holdings, Inc. trades at $59.1 (market cap $50.47B). The key difference: PayPal Holdings, Inc. is far larger — about 4.7× Cytokinetics Inc's market cap, and PayPal Holdings, Inc. pays a 0.95% dividend while Cytokinetics Inc pays none. Which is the better fit depends on your goals.
| CYTK | PYPL | |
|---|---|---|
Market Cap | $10.63B | $50.47B |
Sector | Technology | Financials |
52-Week High | $87.26 | $76.13 |
52-Week Low | $34.31 | $39.08 |
Enterprise Value | $10.74B | $52.62B |
Dividend Yield | — | 0.95% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Cytokinetics (CYTK) trades at $75.64, down 2.39% on the day, amid a bearish technical signal despite a Q2 2026 earnings beat. The stock shows negative profitability with a net income margin of -1,321.12% and a high P/S ratio of 140.65, reflecting significant losses and premium valuation relative to sales. Recent news highlights strong uptake of MYQORZO and UK regulatory approval, supporting commercial momentum.
The outlook is polarized: analyst consensus is strongly bullish with a $111.14 price target, but high cash burn and competitive pressures pose risks. Investment opportunity hinges on MYQORZO's market expansion, while execution and funding needs remain key challenges for shareholders.
PayPal (PYPL) trades at $58.73, down 0.58% today, with a bullish technical signal and strong fundamentals including a P/E of 11.15 and net income margin of 14.36%. Recent Q2 2026 earnings beat expectations with EPS of $1.38, and news highlights acquisition interest from Stripe and Advent International, though the board rejected a $53 billion offer as too low, signaling confidence in the turnaround under new leadership.
The outlook is positive with raised 2026 guidance and robust free cash flow growth, but risks include competitive pressures and economic sensitivity. Analysts are mixed with a $58.75 consensus target, slightly above the current price, suggesting moderate upside potential amid ongoing execution risks.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Cytokinetics Inc
Cytokinetics is a biopharmaceutical company focused on muscle biology. It develops muscle activators and inhibitors as potential treatments for debilitating diseases where muscle performance is compromised or declining.
Read more on CYTK →About PayPal Holdings, Inc.
PayPal Holdings, Inc. operates as a technology platform company that enables digital and mobile payments on behalf of consumers and merchants. The Company offers online payment solutions. PayPal Holdings serves customers worldwide.
Read more on PYPL →
